MainStreet Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.7M | Sell |
53,860
-1,442
| -3% | -$320K | 1.76% | 15 |
|
|
2025
Q4 | $12.6M | Sell |
55,302
-5,225
| -9% | -$1.19M | 1.82% | 14 |
|
|
2025
Q3 | $14M | Sell |
60,527
-2,200
| -4% | -$448K | 1.88% | 12 |
|
|
2025
Q2 | $11.6M | Sell |
62,727
-1,345
| -2% | -$250K | 1.61% | 17 |
|
|
2025
Q1 | $13.4M | Sell |
64,072
-3,008
| -4% | -$585K | 1.95% | 11 |
|
|
2024
Q4 | $11.9M | Sell |
67,080
-1,078
| -2% | -$198K | 1.67% | 15 |
|
|
2024
Q3 | $13.5M | Sell |
68,158
-6,465
| -9% | -$1.21M | 1.79% | 13 |
|
|
2024
Q2 | $12.8M | Sell |
74,623
-34,675
| -32% | -$5.74M | 1.57% | 16 |
|
|
2024
Q1 | $19.9M | Sell |
109,298
-3,474
| -3% | -$599K | 2.39% | 8 |
|
|
2023
Q4 | $17.5M | Sell |
112,772
-2,400
| -2% | -$350K | 1.98% | 11 |
|
|
2023
Q3 | $17.2M | Sell |
115,172
-1,888
| -2% | -$277K | 2% | 12 |
|
|
2023
Q2 | $15.8M | Sell |
117,060
-3,014
| -3% | -$442K | 1.71% | 14 |
|
|
2023
Q1 | $19.1M | Buy |
120,074
+3,300
| +3% | +$505K | 2.07% | 11 |
|
|
2022
Q4 | $18.9M | Sell |
116,774
-5,149
| -4% | -$790K | 2.11% | 12 |
|
|
2022
Q3 | $16.4M | Hold |
121,923
| – | – | 1.99% | 11 |
|
|
2022
Q2 | $18.7M | Sell |
121,923
-18,765
| -13% | -$2.87M | 2.14% | 11 |
|
|
2022
Q1 | $22.8M | Sell |
140,688
-1,916
| -1% | -$278K | 2.13% | 9 |
|
|
2021
Q4 | $19.3M | Sell |
142,604
-854
| -0.6% | -$101K | 1.68% | 15 |
|
|
2021
Q3 | $15.5M | Buy |
143,458
+33,460
| +30% | +$3.82M | 1.49% | 18 |
|
|
2021
Q2 | $12.4M | Buy |
109,998
+568
| +0.5% | +$64K | 1.06% | 25 |
|
|
2021
Q1 | $11.8M | Sell |
109,430
-1,539
| -1% | -$165K | 0.99% | 27 |
|
|
2020
Q4 | $11.9M | Sell |
110,969
-11,909
| -10% | -$1.14M | 0.95% | 28 |
|
|
2020
Q3 | $10.8M | Sell |
122,878
-17,047
| -12% | -$1.6M | 0.84% | 31 |
|
|
2020
Q2 | $13.7M | Buy |
139,925
+15,419
| +12% | +$1.36M | 0.94% | 23 |
|
|
2020
Q1 | $9.49M | Buy |
124,506
+8,341
| +7% | +$710K | 1.17% | 22 |
|
|
2019
Q4 | $10.3M | Buy |
116,165
+5,365
| +5% | +$445K | 1.13% | 22 |
|
|
2019
Q3 | $8.39M | Sell |
110,800
-5
| -0% | -$343 | 1.1% | 25 |
|
|
2019
Q2 | $8.06M | Buy |
110,805
+1,484
| +1% | +$117K | 1.05% | 28 |
|
|
2019
Q1 | $8.81M | Buy |
109,321
+7,325
| +7% | +$599K | 1.25% | 22 |
|
|
2018
Q4 | $9.4M | Buy |
101,996
+436
| +0.4% | +$38.3K | 1.45% | 17 |
|
|
2018
Q3 | $9.61M | Buy |
101,560
+14,916
| +17% | +$1.41M | 1.29% | 19 |
|
|
2018
Q2 | $8.03M | Buy |
86,644
+3,507
| +4% | +$343K | 1.16% | 22 |
|
|
2018
Q1 | $7.87M | Buy |
83,137
+61
| +0.1% | +$6.7K | 1.21% | 21 |
|
|
2017
Q4 | $8.03M | Buy |
+83,076
| New | +$7.83M | 1.23% | 22 |
|
Other funds holding ABBV
VCM
VPM
MainStreet Investment Advisors's ABBV Position: Q1 2026 in Review
MainStreet Investment Advisors reduced its AbbVie (ABBV) stake by 2.6% in Q1 2026, selling an estimated $320K and leaving 53,860 shares worth $11.7M. The position accounts for 1.76% of the portfolio, ranked #15.
MainStreet Investment Advisors first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $22.8M in Q1 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- MainStreet Investment Advisors held 53,860 shares of AbbVie worth $11.7M as of Q1 2026.
- MainStreet Investment Advisors sold 1,442 AbbVie shares in Q1 2026, an estimated $320K.
- AbbVie made up 1.76% of MainStreet Investment Advisors's portfolio in Q1 2026, its #15 holding.
- MainStreet Investment Advisors first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- MainStreet Investment Advisors's AbbVie position peaked at $22.8M in Q1 2022.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on MainStreet Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.